KOREASCHOLAR

쥐 종양 모델에서 인디루빈 유도체인 5-nitro-indirubinoxime에 의한 종양 억제 효과 Anti-Tumor Activity of Novel Indirubin Derivatives in Rat Tumor Model

김수아, 홍광진, 황덕호, 김대환, 이하형, 안상건, 윤정훈
  • 언어KOR
  • URLhttp://db.koreascholar.com/Article/Detail/324641
대한구강악안면병리학회지
제31권 제2호 (2007.04)
pp.69-76
대한구강악안면병리학회 (Korean Academy Of Oral And Maxillofacial Pathology)
초록

Indirubin is the ac ti ve ingredi ent of a traditional Chinese herbal medicine, Danggui Longhui Wan, used for t he t reatment of chronic myelocytic leukemia Here, we report that novel indirubin ,- 11‘ ivative‘ 5’ - nitro-indirubinoxime (5’ NIO) , has potent anti- proliferative activity on va rious human cancel‘ cells and oncogenic RK3E- ras rat kidney cells with ha lf- inhibi tory concentrati ons (1C50) ra nging from 1- 12 M, Treatment with indirubin derivative induced the activation 01' caspase 7 rollowed by apoptos is in RK3E- ras cells. lndirubin derivative showed strong anti-tumor activity in rat solid and oral tUll10r models , Direct inj ection of indirubin deri vative every other day for 10 days induced signifi cant inhi bition of tumor growth in Sprague-Dawley rats bearing RK3E- ras-induced tumors Histologically. t reatment with indiru bin de ri vative caused s ignifi cant inhi bit ion of tumor formation with increased apoptosis and decreased tumor cell prolife ration, These f indings provide the potent ial va lue of indirubin deri vative a s a novel candidate for ant i-tumor agents

저자
  • 김수아(동국대학교 한의과대학 생화확교실) | Soo A Kim
  • 홍광진(조선대학교 치과대학 병리학교실) | Kwang Jin Hong
  • 황덕호(조선대학교 치과대학 병리학교실) | Deok Ho Whang
  • 김대환(조선대학교 치과대학 병리학교실) | Dea Whan Kim
  • 이하형(조선대학교 치과대학 병리학교실) | Ha Hyung Lee
  • 안상건(조선대학교 치과대학 병리학교실) | Sang Gun Ahn Correspondence
  • 윤정훈(조선대학교 치과대학 병리학교실) | Jung Hoon Yoon Correspondence